Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
12.73
-0.10 (-0.78%)
At close: May 01, 2025, 3:59 PM
12.70
-0.24%
After-hours: May 01, 2025, 04:05 PM EDT
Tekla Life Sciences Investors Revenue
Tekla Life Sciences Investors reported an annual revenue of $86.69M, reflecting a 268.5% growth. For the quarter ending September 30, 2024, Tekla Life Sciences Investors generated $1.91M in revenue.
Revenue (ttm)
$86.69M
Revenue Growth
268.5%
Price / Sales Ratio
0
Revenue / Employee
-
Employees
undefined
Market Cap
367.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Sep 30, 2024 | 86.69M | +268.50% |
| Sep 30, 2023 | 23.52M | +-122.78% |
| Sep 30, 2022 | -103.25M | -257.18% |
| Sep 30, 2021 | 65.69M | -47.06% |
| Sep 30, 2020 | 124.08M | n/a |